• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PLXP

PLXP

PLx Pharma Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD0.09

+0.00 (+0.00%)

Company Profile

CEO

Natasha Giordano

IPO Date

2014-03-13

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.10

Prev. Close

$0.09

Day Low

$0.08

Day High

$0.16

52W Low

$0.01

52W High

$3.41

Market Cap

$0.00B

Volume

50.38M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

40.0%

Avg Negative

2.0%

Avg Neutral

58.0%

News Feed

PLx Pharma Inc.'s VAZALORE to Launch in Over 2,400 Rite Aid Stores in August

GlobeNewsWire·7/26/2021·↑ positive

PLx Pharma Inc. to Discuss 2021 Second Quarter Financial Results on August 6, 2021 Conference Call and Provide Business Update

GlobeNewsWire·7/22/2021·↑ positive

Why PLx Pharma Blasted Nearly 20% Higher Today

The Motley Fool·7/20/2021
·↑ positive

PLXP Stock Increases Over 10% Pre-Market: Why It Happened

Pulse2·7/20/2021·↑ positive

PLx Pharma Inc.'s VAZALORE to Launch in over 8,000 Walgreens Stores Nationwide in August

GlobeNewsWire·7/19/2021·↑ positive

PLXP Stock Increases Over 20% Pre-Market: Why It Happened

Pulse2·7/13/2021·↑ positive

PLx Pharma Inc.'s VAZALORE to Launch in over 4,500 Walmart Stores Nationwide in August

GlobeNewsWire·7/12/2021·↑ positive

PLx Pharma Inc. to Present at Upcoming Healthcare Industry Conferences

GlobeNewsWire·6/9/2021·↑ positive

PLx Pharma Inc. (PLXP) CEO Natasha Giordano on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/14/2021·↓ negative

PLx Pharma Inc. Reports First Quarter 2021 Results and Provides Business Update

GlobeNewsWire·5/14/2021·↑ positive